Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Elon Musk took the stage for Tesla's 2023 Investor Day in Austin, Texas and unveiled what he called the company's Master Plan 3, which emphasizes "sustainable energy for all of Earth."
COVID-19's origins remain hazy. Three years after the start of the pandemic, it's still unclear whether the coronavirus that causes the disease leaked from a lab or spread to humans from an animal.
Abortion pills could be difficult to get as a federal judge in Texas is expected to rule as early as today if the FDA's approval of the drug will be overturned.
The Ohio Department of Natural Resources estimated that more than 38,000 minnows died with 5,500 additional species of fish, amphibians, and crayfish also possibly impacted by the toxic spill.
